{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:21:05Z","timestamp":1793409665549,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12026-024-09526-0","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T04:02:07Z","timestamp":1723521727000},"page":"1268-1276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["New mutations and new phenotypes: a case of Major Histocompatibility Complex Class II Deficiency"],"prefix":"10.1007","volume":"72","author":[{"given":"Xinting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0002-944X","authenticated-orcid":false,"given":"Xiaoli","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"9526_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.clim.2019.04.012","volume":"203","author":"C Posovszky","year":"2019","unstructured":"Posovszky C, et al. Persisting enteropathy and disturbed adaptive mucosal immunity due to MHC class II deficiency. Clin Immunol. 2019;203:125\u201333.","journal-title":"Clin Immunol"},{"issue":"2","key":"9526_CR2","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1046\/j.1365-2141.2001.03105.x","volume":"115","author":"HM Wolf","year":"2001","unstructured":"Wolf HM, et al. Residual expression of functional MHC class II molecules in twin brothers with MHC class II deficiency is cell type specific. Br J Haematol. 2001;115(2):460\u201371.","journal-title":"Br J Haematol"},{"issue":"4","key":"9526_CR3","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10875-013-9863-8","volume":"33","author":"I Ben-Mustapha","year":"2013","unstructured":"Ben-Mustapha I, et al. Clinical, immunological and genetic findings of a large Tunisian series of major histocompatibility complex class II deficiency patients. J Clin Immunol. 2013;33(4):865\u201370.","journal-title":"J Clin Immunol"},{"key":"9526_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev.immunol.19.1.331","volume":"19","author":"W Reith","year":"2001","unstructured":"Reith W, Mach B. The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol. 2001;19:331\u201373.","journal-title":"Annu Rev Immunol"},{"key":"9526_CR5","doi-asserted-by":"crossref","unstructured":"DeSandro AM, Nagarajan UM, Boss JM. Associations and interactions between bare lymphocyte syndrome factors. Mol Cell Biol. 2000;20(17):6587\u201399.","DOI":"10.1128\/.20.17.6587-6599.2000"},{"issue":"2","key":"9526_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/bmt.2012.140","volume":"48","author":"TN Small","year":"2013","unstructured":"Small TN, et al. Alternative donor SCT for the treatment of MHC class II deficiency. Bone Marrow Transplant. 2013;48(2):226\u201332.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"9526_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jaci.2014.06.001","volume":"134","author":"S Hanna","year":"2014","unstructured":"Hanna S, Etzioni A. MHC class I and II deficiencies. J Allergy Clin Immunol. 2014;134(2):269\u201375.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"9526_CR8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.jaip.2018.07.046","volume":"7","author":"RE El Hawary","year":"2019","unstructured":"El Hawary RE, et al. MHC-II deficiency among Egyptians: novel mutations and unique phenotypes. J Allergy Clin Immunol Pract. 2019;7(3):856\u201363.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"9526_CR9","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0022-3476(05)80388-9","volume":"123","author":"C Klein","year":"1993","unstructured":"Klein C, et al. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr. 1993;123(6):921\u20138.","journal-title":"J Pediatr"},{"key":"9526_CR10","doi-asserted-by":"publisher","first-page":"108932","DOI":"10.1016\/j.clim.2022.108932","volume":"235","author":"M Damoiseaux","year":"2022","unstructured":"Damoiseaux M, et al. Lessons learned from the diagnostic work-up of a patient with the bare lymphocyte syndrome type II. Clin Immunol. 2022;235:108932.","journal-title":"Clin Immunol"},{"issue":"6","key":"9526_CR11","doi-asserted-by":"publisher","first-page":"e13774","DOI":"10.1111\/petr.13774","volume":"24","author":"LM Castano-Jaramillo","year":"2020","unstructured":"Castano-Jaramillo LM, et al. Meta-analysis of hematopoietic stem cell transplantation in major histocompatibility complex class II deficiency. Pediatr Transplant. 2020;24(6):e13774.","journal-title":"Pediatr Transplant"},{"issue":"19","key":"9526_CR12","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1182\/blood-2011-05-352716","volume":"118","author":"M Ouederni","year":"2011","unstructured":"Ouederni M, et al. Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood. 2011;118(19):5108\u201318.","journal-title":"Blood"},{"issue":"3","key":"9526_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10875-024-01674-0","volume":"44","author":"FJ Alroqi","year":"2024","unstructured":"Alroqi FJ, et al. Novel presentation of Major Histocompatibility Complex Class II Deficiency with hemophagocytic lymphohistiocytosis. J Clin Immunol. 2024;44(3):73.","journal-title":"J Clin Immunol"},{"issue":"1","key":"9526_CR14","doi-asserted-by":"publisher","first-page":"e13335","DOI":"10.1111\/sji.13335","volume":"99","author":"H \u00dcnsal","year":"2024","unstructured":"\u00dcnsal H, et al. A large single-center cohort of bare lymphocyte syndrome: Immunological and genetic features in Turkey. Scand J Immunol. 2024;99(1):e13335.","journal-title":"Scand J Immunol"},{"issue":"8","key":"9526_CR15","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s10875-023-01562-z","volume":"43","author":"MS Mousavi Khorshidi","year":"2023","unstructured":"Mousavi Khorshidi MS, et al. Clinical, immunological, and genetic findings in Iranian patients with MHC-II Deficiency: confirmation of c.162delG RFXANK founder mutation in the Iranian population. J Clin Immunol. 2023;43(8):1941\u201352.","journal-title":"J Clin Immunol"},{"issue":"3","key":"9526_CR16","doi-asserted-by":"publisher","first-page":"e586","DOI":"10.1212\/NXG.0000000000000586","volume":"7","author":"E Alharby","year":"2021","unstructured":"Alharby E, et al. Progressive ataxia and neurologic regression in RFXANK-associated bare lymphocyte syndrome. Neurol Genet. 2021;7(3):e586.","journal-title":"Neurol Genet"},{"issue":"8","key":"9526_CR17","doi-asserted-by":"publisher","first-page":"ofaa314","DOI":"10.1093\/ofid\/ofaa314","volume":"7","author":"YQ Cai","year":"2020","unstructured":"Cai YQ, et al. A novel RFXANK mutation in a Chinese child with MHC II deficiency: case report and literature review. Open Forum Infect Dis. 2020;7(8):ofaa314.","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"9526_CR18","first-page":"594","volume":"17","author":"F Abolnezhadian","year":"2018","unstructured":"Abolnezhadian F, Saeedi-Boroujeni A, Iranparast S. MHC Class II Deficiency with normal CD4+ T cell counts: a case report. Iran J Allergy Asthma Immunol. 2018;17(6):594\u2013600.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"3","key":"9526_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.aller.2017.04.006","volume":"46","author":"S Farrokhi","year":"2018","unstructured":"Farrokhi S, et al. MHC class II deficiency: report of a novel mutation and special review. Allergol Immunopathol (Madr). 2018;46(3):263\u201375.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"5","key":"9526_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10875-017-0402-x","volume":"37","author":"RM Shah","year":"2017","unstructured":"Shah RM, et al. Enterovirus-related immune reconstitution inflammatory syndrome (IRIS) following haploidentical stem cell transplantation in an MHC class II-deficient child. J Clin Immunol. 2017;37(5):419\u201321.","journal-title":"J Clin Immunol"},{"issue":"1","key":"9526_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s10875-015-0219-4","volume":"36","author":"K Clarridge","year":"2016","unstructured":"Clarridge K, et al. Major Histocompatibility Complex Class II Deficiency due to a novel mutation in RFXANK in a child of Mexican descent. J Clin Immunol. 2016;36(1):4\u20135.","journal-title":"J Clin Immunol"},{"issue":"3","key":"9526_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10875-012-9831-8","volume":"33","author":"W Al-Herz","year":"2013","unstructured":"Al-Herz W, et al. Major histocompatibility complex class II deficiency in Kuwait: clinical manifestations, immunological findings and molecular profile. J Clin Immunol. 2013;33(3):513\u20139.","journal-title":"J Clin Immunol"},{"issue":"11","key":"9526_CR23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00251-002-0521-1","volume":"54","author":"W Wiszniewski","year":"2003","unstructured":"Wiszniewski W, et al. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II. Immunogenetics. 2003;54(11):747\u201355.","journal-title":"Immunogenetics"},{"issue":"8","key":"9526_CR24","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00251-003-0609-2","volume":"55","author":"T Prod'homme","year":"2003","unstructured":"Prod\u2019homme T, et al. Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course. Immunogenetics. 2003;55(8):530\u20139.","journal-title":"Immunogenetics"},{"issue":"9","key":"9526_CR25","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.4049\/jimmunol.166.9.5681","volume":"166","author":"AM Lennon-Dum\u00e9nil","year":"2001","unstructured":"Lennon-Dum\u00e9nil AM, et al. Uncoordinated HLA-D gene expression in a RFXANK-defective patient with MHC class II deficiency. J Immunol. 2001;166(9):5681\u20137.","journal-title":"J Immunol"},{"issue":"4\u20135","key":"9526_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s002510050619","volume":"51","author":"W Wiszniewski","year":"2000","unstructured":"Wiszniewski W, et al. Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B. Immunogenetics. 2000;51(4\u20135):261\u20137.","journal-title":"Immunogenetics"},{"issue":"7","key":"9526_CR27","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.4049\/jimmunol.164.7.3666","volume":"164","author":"UM Nagarajan","year":"2000","unstructured":"Nagarajan UM, et al. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells. J Immunol. 2000;164(7):3666\u201374.","journal-title":"J Immunol"},{"issue":"4","key":"9526_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12026-020-09141-9","volume":"68","author":"F Abolnezhadian","year":"2020","unstructured":"Abolnezhadian F, et al. A novel mutation in RFXANK gene and low B cell count in a patient with MHC class II deficiency: a case report. Immunol Res. 2020;68(4):225\u201331.","journal-title":"Immunol Res"},{"key":"9526_CR29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13223-016-0166-5","volume":"12","author":"S Sheikhbahaei","year":"2016","unstructured":"Sheikhbahaei S, et al. Gene mutations responsible for primary immunodeficiency disorders: a report from the first primary immunodeficiency biobank in Iran. Allergy Asthma Clin Immunol. 2016;12:62.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"9526_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jacig.2022.08.006","volume":"2","author":"S Ramanathan","year":"2023","unstructured":"Ramanathan S, et al. Haploidentical CD3(+) TCR \u03b1\u03b2\/CD19(+)-depleted HSCT for MHC class II deficiency and persistent SARS-CoV-2 pneumonitis. J Allergy Clin Immunol Glob. 2023;2(1):101\u20134.","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"5","key":"9526_CR31","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/tid.12263","volume":"16","author":"RF Abu-Arja","year":"2014","unstructured":"Abu-Arja RF, et al. Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with Bare Lymphocyte Syndrome type II. Transpl Infect Dis. 2014;16(5):830\u20137.","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"9526_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1074-7613(03)00086-4","volume":"18","author":"N Nekrep","year":"2003","unstructured":"Nekrep N, et al. When the lymphocyte loses its clothes. Immunity. 2003;18(4):453\u20137.","journal-title":"Immunity"},{"issue":"1","key":"9526_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1476-7961-10-6","volume":"10","author":"N Guirat-Dhouib","year":"2012","unstructured":"Guirat-Dhouib N, et al. Oral HPV infection and MHC class II deficiency (A study of two cases with atypical outcome). Clin Mol Allergy. 2012;10(1):6.","journal-title":"Clin Mol Allergy"},{"issue":"1","key":"9526_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1710-1492-8-14","volume":"8","author":"R Djidjik","year":"2012","unstructured":"Djidjik R, et al. Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency. Allergy Asthma Clin Immunol. 2012;8(1):14.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"9","key":"9526_CR35","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00431-010-1179-6","volume":"169","author":"H Naamane","year":"2010","unstructured":"Naamane H, et al. The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population. Eur J Pediatr. 2010;169(9):1069\u201374.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"9526_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1074-7613(00)80016-3","volume":"10","author":"UM Nagarajan","year":"1999","unstructured":"Nagarajan UM, et al. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity. 1999;10(2):153\u201362.","journal-title":"Immunity"},{"issue":"3","key":"9526_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/3081","volume":"20","author":"K Masternak","year":"1998","unstructured":"Masternak K, et al. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat Genet. 1998;20(3):273\u20137.","journal-title":"Nat Genet"},{"key":"9526_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","volume":"13","author":"H Al-Samkari","year":"2018","unstructured":"Al-Samkari H, Berliner N. Hemophagocytic Lymphohistiocytosis. Annu Rev Pathol. 2018;13:27\u201349.","journal-title":"Annu Rev Pathol"},{"issue":"6","key":"9526_CR39","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/01.all.0000246626.57118.d9","volume":"6","author":"AH Filipovich","year":"2006","unstructured":"Filipovich AH. Hemophagocytic lymphohistiocytosis and related disorders. Curr Opin Allergy Clin Immunol. 2006;6(6):410\u20135.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"9526_CR40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1378\/chest.13-2852","volume":"146","author":"J Liu","year":"2014","unstructured":"Liu J, et al. Lung ultrasonography for the diagnosis of severe neonatal pneumonia. Chest. 2014;146(2):383\u20138.","journal-title":"Chest"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-024-09526-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-024-09526-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-024-09526-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T05:07:04Z","timestamp":1733288824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-024-09526-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9526"],"URL":"https:\/\/doi.org\/10.1007\/s12026-024-09526-0","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"18 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}